"Both children showed rapid normalization of their LV ejection fraction and B-type
natriuretic protein as well as improvement in D-dimer that were temporally-associated with
remestemcel-L treatment (Figure 1). In addition, serial echocardiographic imaging showed
reduction in the severity of pan-valvular regurgitation as well as increases in LV end systolic
volume. The latter observation is consistent with improvement in LV contractile state that was
temporally-associated with the cell therapy administration"
Doesn't sound like that was consistent with the previous gradual improvement they were showing - disclaimer 'I'm not a doctor'
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-47
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.28 |
Change
-0.035(1.52%) |
Mkt cap ! $2.918B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.39 | $2.24 | $12.25M | 5.309M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 101061 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 80020 | 37 |
View Market Depth
| Last trade - 15.54pm 22/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |